Home > Insider Trading > Filing (0001225208-16-028427)

Filing Details

Accession Number:: 0001225208-16-028427
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-26 16:29:00
Reporting Period:: 2016-02-24

Filing Date:: 2016-02-26
Accepted Time:: 2016-02-26 16:29:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595612	J. Daniel Brennan	300 Boston Scientific Way Marlborough MA 01752-1234	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-02-24	40,214	$8.30	202,659	No	4	M	Direct
Common Stock	Acquisiton	2016-02-24	20,461	$7.41	223,120	No	4	M	Direct
Common Stock	Acquisiton	2016-02-24	12,422	$7.16	235,542	No	4	M	Direct
Common Stock	Acquisiton	2016-02-24	7,572	$7.39	243,114	No	4	M	Direct
Common Stock	Acquisiton	2016-02-24	6,093	$6.28	249,207	No	4	M	Direct
Common Stock	Acquisiton	2016-02-24	5,734	$0.00	254,941	No	4	M	Direct
Common Stock	Disposition	2016-02-24	2,701	$17.33	252,240	No	4	F	Direct
Common Stock	Disposition	2016-02-24	99,591	$17.21	152,649	No	4	S	Direct
Common Stock	Disposition	2016-02-25	3,620	$17.48	149,029	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Deferred Stock Units	Disposition	2016-02-24	5,734	$0.00	5,734	$0.00
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-24	20,461	$0.00	20,461	$7.41
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-24	40,214	$0.00	40,214	$8.30
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-24	6,093	$0.00	6,093	$6.28
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-24	12,422	$0.00	12,422	$7.16
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-24	7,572	$0.00	7,572	$7.39

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,202	2019-02-24	No	4	M	Direct
81,847	2020-02-16	No	4	M	Direct
0	2019-02-24	No	4	M	Direct
24,373	2022-02-27	No	4	M	Direct
49,690	2021-02-28	No	4	M	Direct
30,288	2023-02-28	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.11 to $17.32, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 102,308 shares of common stock on February 16, 2010. This option is fully vested.
Grant to the reporting person of an option to purchase 40,214 shares of common stock on February 24, 2009. This option is fully vested.
Grant to the reporting person of an option to purchase 30,466 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase 37,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.